Vidac Pharma to list on Hamburg Stock Exchange
The Israeli clinical stage oncology drug developer has a share subscription facility of up to €20 million from Luxembourg-based GEM.
Stay updated with breaking news from Loren Becker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Israeli clinical stage oncology drug developer has a share subscription facility of up to €20 million from Luxembourg-based GEM.
Poppyseed for the mainstream, chocolate for the addicted, vanilla cream for those who like it gooey, and Lotus spread for the innovative – four variations of traditional Purim treats
As summer arrives, the COVID-19 pandemic appears to have turned a corner â in the U.S., at least, with all 50 states seeing the number of cases decline. As vaccinations have increased and supply starts to outstrip demand, life appears to be returning to some semblance of normalcy. Thatâs far from the case in most countries around the world, where the pandemic is raging unabated. At the heart of the issue is a lack of vaccine access: Many low-income countries standing in line for doses may not be able to distribute them and inoculate their populations until 2023. The Serum Institute ...